Literature DB >> 37613

Characterization of two new enzymatic activities of the rat ventral prostate: 5 alpha-androstane-3 beta, 17 beta-diol 6 alpha-hydroxylase and 5 alpha-androstane-3 beta, 17 beta-diol 7 alpha-hydroxylase.

J T Isaacs, I R McDermott, D S Coffey.   

Abstract

This study has characterized two new enzymatic hydroxylase activities specific for 5 alpha-androstane-3 beta, 17 beta-diol (3 beta-diol) in the rat ventral prostate: 5 alpha-androstane-3 beta, 17 beta-diol 6 alpha-hydroxylase (6 alpha-hydroxylase) and 5 alpha-androstane-3 beta, 17 beta-diol 7 alpha-hydroxylase (7 alpha-hydroxylase). Both of these irreversible hydroxylase activities require NADPH and are localized in the microsomal fraction of the prostate. The apparent Km for 3 beta-diol is 2.5 microM for both the 6 alpha- and 7 alpha-hydroxylase activities. The apparent Km for NADPH is 7.6 microM for the 6 alpha-hydroxylase and 7.0 microM for the 7 alpha-hydroxylase. The pH optimum for both activities is 7.4. Several steroid inhibitors of these hydroxylase activities in vitro were identified including cholesterol, progesterone, and estradiol. Estradiol was found in vitro to be a noncompetitive inhibitor (Ki = 5 microM). Injection of estradiol into intact male rats, simultaneously receiving exogenous testosterone, also produced a significant lowering of the 6 alpha-plus 7 alpha-hydroxylase activities. Both the 6 alpha- and 7 alpha-hydroxylase were found to be androgen sensitive. Following castration there is a rapid decrease in both activities.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37613     DOI: 10.1016/0039-128x(79)90116-8

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  7 in total

1.  Early onset of puberty and early ovarian failure in CYP7B1 knockout mice.

Authors:  Yoko Omoto; Richard Lathe; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

2.  Orally administered melatonin stimulates the 3 alpha/beta-hydroxysteroid oxidoreductase but not the 5 alpha-reductase in the ventral prostate and seminal vesicles of pinealectomized rats.

Authors:  H J Horst; A Buck; K U Adam
Journal:  Experientia       Date:  1982-08-15

3.  An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.

Authors:  Zhang Weihua; Richard Lathe; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

4.  cyp7b1 catalyses the 7alpha-hydroxylation of dehydroepiandrosterone and 25-hydroxycholesterol in rat prostate.

Authors:  C Martin; R Bean; K Rose; F Habib; J Seckl
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

5.  Neurosteroid metabolism. 7 alpha-Hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes.

Authors:  Y Akwa; R F Morfin; P Robel; E E Baulieu
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

6.  The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.

Authors:  Matthew J Sikora; Kevin E Cordero; Jose M Larios; Michael D Johnson; Marc E Lippman; James M Rae
Journal:  Breast Cancer Res Treat       Date:  2008-06-04       Impact factor: 4.872

Review 7.  Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.

Authors:  Tetsuya Fujimura; Kenichi Takayama; Satoru Takahashi; Satoshi Inoue
Journal:  Cancers (Basel)       Date:  2018-01-23       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.